AyuVis Research
Fort Worth, US · Founded 2018 · Texas corporation
Find your way into AyuVis Research
40 people in our graph share verified history with the AyuVis Research team — schools, employers, funds. One of them is your warm intro.
AyuVis develops novel small-molecule immunotherapies with a unique mode of action to fight inflammation and infection. Founded in 2014, the company focuses on drug discovery and clinical development in areas including neonatal immunology and infectious disease.
Founders & leadership
AyuVis Research was founded in 2018 by Suchismita Acharya and Suchi Acharya.


Reported raises · per SEC filings
Form D private placements$2M disclosed across 2 rounds · 2018–2019
▶$745KraisedOct 2019 · 17 investors · PharmaceuticalsRule 506(b)
- Gagan AcharyaDirector
- Stella M RobertsonDirector
- Dwight HortonExecutive Officer
- Beamon AgarwalExecutive Officer
- William Dennis DeanExecutive Officer
- Suchismita AcharyaExecutive Officer, Director
- Russell BromleyExecutive Officer
- Offering amount
- $750K
- Amount sold
- $745K
- Proceeds to insiders
- $60K
- First sale
- Apr 2019
- Incorporated
- Corporation, Texas, 2018
- Federal exemptions
- 06b
▶$1.3MraisedApr 2019 · 26 investors · PharmaceuticalsRule 506(b)
- Suchismita AcharyaExecutive Officer, Director
- Gagan AcharyaExecutive Officer, Director
- Stella M RobertsonDirector
- Offering amount
- $1.3M
- Amount sold
- $1.3M
- Proceeds to insiders
- $60K
- First sale
- Apr 2018
- Incorporated
- Corporation, Texas, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2022 | $2M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2017 | $273.8K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does AyuVis Research do?
- AyuVis develops novel small-molecule immunotherapies with a unique mode of action to fight inflammation and infection. Founded in 2014, the company focuses on drug discovery and clinical development in areas including neonatal immunology and infectious disease.
- Who founded AyuVis Research?
- AyuVis Research was founded by Suchismita Acharya, Suchi Acharya in 2018.
- How much funding has AyuVis Research raised?
- AyuVis Research has disclosed $2M raised across 2 rounds.
- Where is AyuVis Research headquartered?
- AyuVis Research is headquartered in Fort Worth, US.

